STRAMSEN BIOTECH, INC
Invest with us
Stramsen Biotech Inc. is proud to offer an exceptional investment opportunity to a diverse range of investors, including individuals, hedge funds, and venture capitalists. As we approach the final stages of our Regulation A offering approval process, we're excited to announce that we're currently raising funds through a Regulation D offering. To ensure a seamless and professional investment experience, we've partnered with a prestigious broker-dealer to facilitate capital raising for both our Regulation A and Regulation D offerings.
​​
Stramsen Biotech Inc. is an innovative, venture-backed biotech company at the forefront of plant-based medicine development. Our mission is to transform patient care through groundbreaking biopharmaceutical solutions.
​
We are proud to be backed by our lead investor, GEM Global Yield LLC SCS, a multi-billion dollar private equity firm. This strategic partnership not only underscores our company's immense potential but also positions us as a leader in biopharmaceutical innovation.
patient care through groundbreaking biopharmaceutical solutions.​ompany's immense potential but also positions us as a leader in biopharmaceutical innovation.
​
​
As of June 2025, Stramsen Biotech Inc. boasts a robust equity capital structure designed to support its ambitious growth plans. The company has authorized 750 million shares, with approximately 229,041,217 shares currently outstanding. Based on the most recent valuation of $6.5 billion, our share price in the private market stands at approximately $28.38 per share. This valuation reflects the market's confidence in our innovative biotech solutions and potential for future growth.
​
Act now to secure your stake in the future of healthcare. With Stramsen Biotech Inc., you're not just investing in a company; you're investing in a vision that could transform countless lives. Don't let this unparalleled opportunity slip away!
​
In a strategic move to enhance our investor relations and capital management capabilities, Stramsen Biotech Inc. has forged a powerful alliance with Nasdaq Private Market, a specialized division of the renowned Nasdaq exchange. This New York-based broker-dealer excels in facilitating transactions in both private secondary and primary markets, providing unparalleled opportunities for the sale of company and shareholders' shares. This partnership not only streamlines our ability to connect with potential investors but also empowers us to manage our capital structure with unprecedented efficiency.
​
We invite you to be part of our groundbreaking journey in plant-based drug development. To explore the exciting investment opportunities with Stramsen Biotech Inc., please reach out to our esteemed Management team:
​
-
Office Direct
Phone: 713-955-1156​
​
-
Email: info@stramsenbiotech.com
​
-
Direct CEO contact:
​
​At Stramsen Biotech Inc., we are committed to nurturing strong, transparent relationships with our investors. Our dedicated team stands ready to provide you with comprehensive insights into our innovative plant-based drug development pipeline and the transformative potential it holds. Don't miss this chance to be part of a revolution in pharmaceutical development – contact us today to learn how you can contribute to and benefit from our vision for a healthier future.
​
Homepage - Nasdaq Private Market
​
​